Moscow is seeking new partnerships in business and other sectors to strengthen economic ti...
An oil spill from a damaged tanker in the Strait of Hormuz has reached the UAE’s beaches,...
In 1921, $700 could buy a two-chair barber shop, a thriving urban newsstand, or even a pai...
Three weeks into the siege of Yemen’s third-largest city, prices have doubled, and familie...
When you’re traveling, having the right essentials in your carry-on can make all the diffe...
Countries
Opinion
Abdul El-Sayed’s toxic ‘academic research’ reveals his anti-American Muslim supremacy
Broke, woke and armed with a crazy plan: Pay the lunatics running the asylum even more
Wannabe tyrants fall to the ‘Streisand effect’ — because censors deserve our mockery
- PR Newswire ( Middle East ) 2026/10/24
BEIJING, Oct. 24, 2026 /PRNewswire/ -- Likang Life Sciences ("Likang"), a biotechnology company advancing AI-enabled personalized cancer imm...
- Gizmodo ( Middle East ) 2026/9/18
Scientists are developing new forms of CAR T cell therapy that may finally be able to treat solid tumors.
- PR Newswire ( Middle East ) 2026/8/12
TAIPEI and SAN DIEGO, Aug. 12, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492) today announced a significant research advance inv...
- PR Newswire ( Middle East ) 2026/8/10
MILWAUKEE, Aug. 10, 2026 /PRNewswire/ -- Reinforcing its commitment to advancing cancer immunotherapy through research and education, the So...
- PR Newswire ( Middle East ) 2026/8/10
Newly recruiting Phase 1 study will evaluate a next-generation KRAS-targeted immunotherapy, revealing how pancreatic tumor microenvironment...
- PR Newswire ( Middle East ) 2026/8/2
Minjuvi® (tafasitamab), in combination with rituximab and lenalidomide, is the first and only chemotherapy-free CD19 and CD20 dual-targeted...
- PR Newswire ( Middle East ) 2026/6/26
Breast cancer vaccine presentation includes final Phase 1 data showing all major primary endpoints were met and protocol-defined immune resp...
- PR Newswire ( Middle East ) 2026/5/22
SAN FRANCISCO and SUZHOU, China, May 21, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmace...
- NY Times News ( Middle East ) 2026/5/4
Thousands of patients across England each year will benefit from a new immunotherapy treatment that can be used for several types of cance...
- PR Newswire ( Middle East ) 2026/4/22
NEWARK, Del., April 22, 2026 /PRNewswire/ -- According to a latest market analysis by Future Market Insights, the global lung cancer therape...
- PR Newswire ( Middle East ) 2026/3/17
Prof. Andreas Lundqvist's group will use Pixelgen's Proximity Network Assay to explore spatial distribution and abundance of single cell sur...
- PR Newswire ( Middle East ) 2026/3/7
SHANGHAI, March 6, 2026 /PRNewswire/ -- Jiahui International Cancer Center (JICC) has stabilized a U.S. patient with advanced non‑small cell...
- PR Newswire ( Middle East ) 2026/3/3
TAIPEI and SAN DIEGO, March 3, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage company focusing on development...
- PR Newswire ( Middle East ) 2026/2/22
More than 60% of participant dietary consumption plans showed no significant difference between omalizumab and multi-food oral immunotherapy...
- PR Newswire ( Middle East ) 2026/1/16
BELLEVUE, Wash., Jan. 16, 2026 /PRNewswire/ -- Vaximm AG, a subsidiary of OSR Holdings, Inc. and a pioneer in oral T-cell immunotherapies fo...